Compartir
Información de la revista
Número
Vol. 25. Núm. 1.Páginas 1-148 (enero - marzo 2024)
Editorials
Vaccine hesitancy: An introduction to its concept
Luis Salleras, Montserrat Salleras, Diana Toledo, Àngela Domínguez
Vacunas. 2024;25:1-4
Vaccination and immunization calendar. Let's not forget history
Fernando Moraga-Llop, José Antonio Navarro-Alonso
Vacunas. 2024;25:5-6
Originals
The prevalence of post-COVID-19 vaccination syndrome and quality of life among COVID-19-vaccinated individuals
Yogendra Shrestha, Rajesh Venkataraman
Vacunas. 2024;25:7-18
COVID-19 vaccines, perceptions and trust amongst vaccine refusers: A qualitative thematic analysis study
Deldar Morad Abdulah, Hawar Abdulrazaq Mohammedsadiq, Pranee Liamputtong
Vacunas. 2024;25:19-29
Attitudes and concerns of Turkish nursing students against the COVID-19 vaccine, willingness to be vaccinated: A cross-sectional study
Zeynep Daşıkan, Mashood Katuntu Waiswa
Vacunas. 2024;25:30-9
Simultaneous detection and genomic characterization of Zika virus Protein M, E and NS1 using optimized primers from Asian and African Lineage
Muhammed Mustapha Suleiman, Olatunji Matthew Kolawole
Vacunas. 2024;25:40-5
Exploring the psychological impact of anxiety, depression, and quality of life in patients with comorbid disease conditions post COVID-19 pandemic era
Anmar Al-Taie, Dania A. Mohd Khalaf, Oritsetimeyin Arueyingho
Vacunas. 2024;25:46-53
Vaccine hesitancy in healthcare professionals and health sciences students of the last courses
Sergi Gomez, Pere Godoy
Vacunas. 2024;25:54-63
Whooping cough surveillance in Catalonia, 2011–2018
Glòria Carmona-Parcerisa, Laura Ruiz-Mitjavila, Carme Fernández-Gutiérrez, Mireia Jané-Checa, Ana Martínez Mateo, Pilar Ciruela Navas
Vacunas. 2024;25:64-70
Broadening criteria for palivizumab administration does not reduce admissions for respiratory syncytial virus
Jessica Gómez Ávila, Juan Iñigo Gil, Beatriz Flores Méndez
Vacunas. 2024;25:71-7
Genetic variants rs1800629 in TNF and rs2228145 in IL6R: Association with adverse event following immunisation (AEFI) and SARS-CoV-2 neutralising antibodies in western Mexico population that received AZD1222 vaccine
Axel Jair Villa-Panduro, Narda M. Corona-Reynaga, Dennis A. Meza-Peña, Mayra Alejandra Enciso Ramírez, Astrid Selene Espinoza García, Jorge Galindo-García, Berenice Sanchez-Caballero, Elia Herminia Valdés-Miramontes, ... Zyanya Reyes-Castillo
Vacunas. 2024;25:78-87
Reviews
mRNA vaccines in gastric cancer: How close are we?
José Dario Portillo-Miño, David Bettin-Gonzalez, Franco Andrés Montenegro Coral
Vacunas. 2024;25:88-96
Recent advancements in cancer vaccines: A systematic review
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, Minakshi Pandey, Avinash Sharma, Himanshu Pandey, Anshu Mishra
Vacunas. 2024;25:97-108
Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform
Fahime Edalat, Fatemeh Hosseini Tabatabaie, Afagh Moattari, Arash Letafati, Jamal Sarvari, Seyed Younes Hosseini
Vacunas. 2024;25:109-27
Prevalence of HCV among patients with HIV in Iran: A systematic review and meta-analysis
Maedeh Hajizadeh, Maryam Moradi Binabaj, Arezoo Asadi, Milad Abdi, Abolfazl Shakiba, Masoumeh Beig, Mohsen Heidary, Mohammad Sholeh
Vacunas. 2024;25:128-39
Current situation of intranasal attenuated vaccines against respiratory syncytial virus in the child population
Jordi Reina, Andrés Suárez
Vacunas. 2024;25:140-6
Special article
Special Article
Letter to the editor
Vaccination impact on long COVID sequelae; a perspective view
Farhad Dadgar, Fatemeh Dehghani, Farzaneh Peikfalak, Masoud Keikha
Vacunas. 2024;25:147-8